Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shaw

Showing results (321-330 of 4,355) with videos related to

Pageof 436
Sort By:
American Journal of Epidemiology|September 1, 1996
Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989-1991E M Velie, G M Shaw
Current Gene Therapy|February 16, 2006
Plasmid-mediated muscle-targeted gene therapy for circulating therapeutic protein replacement: a tale of the tortoise and the hare?Jarupa Ratanamart, James A M Shaw
Journal of the American Society of Nephrology : JASN|August 1, 1993
Effects of cyclosporine and its metabolites in the isolated perfused rat kidneyK A Roby, L M Shaw
Environmental Health Perspectives|September 1, 1995
Neural tube defects--why are rates high among populations of Mexican descent?J A Harris, G M Shaw
European Heart Journal|April 18, 2009
Should beta-blockade continue to be withheld from patients with chronic heart failure and asthma?Steven M Shaw, Simon G Williams
Analytical Biochemistry|August 15, 2009
Quantitative label-free screening for antibodies using scattering biophotonic microarray imagingRouslan V Olkhov, Andrew M Shaw
Clinical Chemistry|November 21, 2009
Use of cerebrospinal fluid biomarkers for diagnosis of incipient Alzheimer disease in patients with mild cognitive impairmentRobert A Dean, Leslie M Shaw
Trends in Biochemical Sciences|May 1, 1991
FACIT collagens: diverse molecular bridges in extracellular matricesL M Shaw, B R Olsen
Critical Care (London, England)|September 14, 2007
Is there more to glycaemic control than meets the eye?J Geoffrey Chase, Geoffrey M Shaw
Urology Practice|April 27, 2023
Editorial CommentaryNathan M Shaw, Lindsay A Hampson
Pageof 436

Showing results (321-330 of 4,355) with videos related to

Sort By:
Pageof 436
American Journal of Epidemiology|September 1, 1996
Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989-1991E M Velie, G M Shaw
Current Gene Therapy|February 16, 2006
Plasmid-mediated muscle-targeted gene therapy for circulating therapeutic protein replacement: a tale of the tortoise and the hare?Jarupa Ratanamart, James A M Shaw
Journal of the American Society of Nephrology : JASN|August 1, 1993
Effects of cyclosporine and its metabolites in the isolated perfused rat kidneyK A Roby, L M Shaw
Environmental Health Perspectives|September 1, 1995
Neural tube defects--why are rates high among populations of Mexican descent?J A Harris, G M Shaw
European Heart Journal|April 18, 2009
Should beta-blockade continue to be withheld from patients with chronic heart failure and asthma?Steven M Shaw, Simon G Williams
Analytical Biochemistry|August 15, 2009
Quantitative label-free screening for antibodies using scattering biophotonic microarray imagingRouslan V Olkhov, Andrew M Shaw
Clinical Chemistry|November 21, 2009
Use of cerebrospinal fluid biomarkers for diagnosis of incipient Alzheimer disease in patients with mild cognitive impairmentRobert A Dean, Leslie M Shaw
Trends in Biochemical Sciences|May 1, 1991
FACIT collagens: diverse molecular bridges in extracellular matricesL M Shaw, B R Olsen
Critical Care (London, England)|September 14, 2007
Is there more to glycaemic control than meets the eye?J Geoffrey Chase, Geoffrey M Shaw
Urology Practice|April 27, 2023
Editorial CommentaryNathan M Shaw, Lindsay A Hampson
Pageof 436